v3.25.2
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
[1]
Current Assets:    
Cash and cash equivalents $ 29,768 $ 35,469
Restricted cash 723 742
Accounts receivable (net of allowance for credit losses of $22 and $23, respectively) 57,454 58,217
Inventories 53,867 49,914
Derivative instruments 2,563 3,313
Other current assets 5,350 5,463
Total current assets 149,725 153,118
Property and equipment, net 207,997 214,742
Other Assets:    
Right of use operating lease assets, net 19,255 20,553
Intangible assets, net 7,885 4,509
Other assets 8,203 8,516
Total other assets 35,343 33,578
Total Assets 393,065 401,438
Current Liabilities:    
Accounts payable 15,705 20,369
Accrued liabilities 16,021 24,214
Current portion – operating leases 4,984 4,851
Derivative instruments 910 1,177
Other current liabilities 4,893 7,193
Total current liabilities 42,513 57,804
Long-term debt, net 118,323 92,904
Operating leases, net of current portion 15,414 16,913
Other liabilities 8,970 8,754
Total Liabilities 185,220 176,375
Commitments and Contingencies (Note 6)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of June 30, 2025 and December 31, 2024; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of June 30, 2025 and December 31, 2024; liquidation preference of $18,075 as of June 30, 2025 1 1
Common stock value 77 77
Additional paid-in capital 1,050,261 1,044,176
Accumulated other comprehensive income 4,975 4,975
Accumulated deficit (847,469) (824,166)
Total Stockholders’ Equity 207,845 225,063
Total Liabilities and Stockholders’ Equity 393,065 401,438
Non-voting Common Stock    
Stockholders’ Equity:    
Common stock value
[1] Amounts derived from the audited consolidated financial statements for the year ended December 31, 2024.

Source